SpectraBase Spectrum ID |
2lIhT0faHtw |
Name |
Fencamfamin |
CAS Registry Number |
1209-98-9 |
Classification |
Pharmaceutical drug, central stimulant |
Comments |
Spectrum verified by independent measurements in external laboratories |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.14 (f) (3) |
DEA Controlled Substance Name |
Fencamfamin |
DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
DEA Controlled Substances Code Number |
1760 |
DEA Schedule |
Schedule IV |
DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers |
Exact Mass |
215.167399680 u |
Formula |
C15H21N |
InChI |
InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3 |
InChIKey |
IKFBPFGUINLYQI-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
215.340 g/mol |
Nominal Mass |
215 u |
Quality |
994 |
Retention Index |
1677 |
SMILES |
C1(C(C2CC1CC2)NCC)C1=CC=CC=C1 |
SPLASH |
splash10-0aos-9510000000-c85299f6214c1d575519 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
N-Ethyl-3-phenyl-norbornan-2-amine |
Technique |
GC/MS |
Wiley ID |
DD2024_001401 |